Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Hepatic Impairment

Clinical trial NCT06161259 · COMPLETED

Trial details

NCT number: NCT06161259
Sponsor: Guangdong Raynovent Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2023-09-14
Primary completion: 2023-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.